Leo C. H. Tsang

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung et al. · Nature Medicine · 2022 · 374 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung et al. · Nature Medicine · 2023 · 203 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung et al. · Nature Communications · 2022 · 69 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

Samuel M. S. Cheng, Chris Ka Pun Mok, Karl CK Chan et al. · Eurosurveillance · 2022 · 36 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +9

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection

Samuel Cheng, Chris KP Mok, John KC Li et al. · Journal of Clinical Virology · 2022 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17